Subject Matter of the Lobbying Activity
|
Specific Topics of Lobbying Communications
|
Intended Outcomes
|
Associated Subject Matters
|
Discuss innovative agreements for reimbursement and the use of RWE in evaluation of pharmaceutical products.
|
- Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
- Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Finances and Budgets, Health, Hospitals, Science and Technology, Senior Citizens
|
Educate on the unmet needs of rare cancers and how to facilitate improved processes within the government to allow for innovation in rare diseases.
|
- Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health, Hospitals, Science and Technology
|
Identify changes to pharmaceutical legislation supporting appropriate government reimbursement of medicines.
|
- Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
- Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Health, Hospitals, Science and Technology, Senior Citizens
|
Raise awareness of the value that innovative medicines provide and demonstrate that Incyte Biosciences Canada supports the growth of the life-science sector in BC.
|
- Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Economic Development and Trade, Health, Hospitals, Science and Technology
|
|